Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications.
作者信息
Mendoza-Pinto C, Escárcega R O, García-Carrasco M, Bailey D J O, Gálvez-Romero J L, Cervera R
机构信息
From the, Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE, Instituto Mexicano del Seguro Social, Puebla, Mexico.
Department of Immunology and Rheumatology, BUAP School of Medicine, Puebla, Mexico.
出版信息
J Intern Med. 2020 Dec;288(6):737-739. doi: 10.1111/joim.13123. Epub 2020 Jun 22.
Abstract
摘要
相似文献
1
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications.病毒感染及其与灾难性抗磷脂综合征的关系：重症新型冠状病毒肺炎血栓形成并发症的一种可能致病机制
J Intern Med. 2020 Dec;288(6):737-739. doi: 10.1111/joim.13123. Epub 2020 Jun 22.
2
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection.COVID-19 感染相关灾难性抗磷脂综合征。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231165736. doi: 10.1177/23247096231165736.
3
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome.抗磷脂综合征中的免疫血栓形成和血管病变机制。
Semin Immunopathol. 2022 May;44(3):347-362. doi: 10.1007/s00281-022-00916-w. Epub 2022 Feb 4.
4
Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer.抗磷脂抗体与新冠病毒感染相关血栓性血管病：一燕不成夏。
Ann Rheum Dis. 2021 Sep;80(9):1105-1107. doi: 10.1136/annrheumdis-2021-220520. Epub 2021 Aug 2.
5
Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?羟氯喹能否预防 COVID-19 相关的血栓事件？
J Microbiol Immunol Infect. 2021 Feb;54(1):37-45. doi: 10.1016/j.jmii.2020.12.010. Epub 2021 Jan 5.
6
COVID-19 and the antiphospholipid syndrome.新型冠状病毒肺炎与抗磷脂综合征。
Autoimmun Rev. 2022 Dec;21(12):103206. doi: 10.1016/j.autrev.2022.103206. Epub 2022 Oct 3.
7
Antiphospholipid syndrome: unusual clinical presentations.抗磷脂综合征：不常见的临床表现。
Thromb Res. 2011 Feb;127 Suppl 3:S47-50. doi: 10.1016/S0049-3848(11)70013-5.
8
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome.抗磷脂抗体和抗磷脂综合征的危险因素。
Semin Thromb Hemost. 2024 Sep;50(6):817-828. doi: 10.1055/s-0043-1776910. Epub 2024 Jan 16.
9
Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant).感染性疾病在抗磷脂综合征（包括其灾难性变异型）中的作用。
Curr Rheumatol Rep. 2018 Aug 20;20(10):62. doi: 10.1007/s11926-018-0773-x.
10
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature.灾难性抗磷脂综合征表现为主动脉弹幕：病例报告及文献复习。
Lupus. 2021 May;30(6):1005-1009. doi: 10.1177/09612033211004728.
引用本文的文献
1
COVID-19 coagulopathy and antiphospholipid syndrome.新型冠状病毒肺炎凝血病与抗磷脂综合征
Rev Colomb Reumatol. 2022 Jun;29:S25-S34. doi: 10.1016/j.rcreu.2021.02.013. Epub 2021 Aug 27.
2
Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19.重症新型冠状病毒肺炎患者的抗磷脂抗体与血管血栓形成
Biomedicines. 2023 Nov 22;11(12):3117. doi: 10.3390/biomedicines11123117.
3
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection.COVID-19 感染相关灾难性抗磷脂综合征。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231165736. doi: 10.1177/23247096231165736.
4
COVID-19 and the antiphospholipid syndrome.新型冠状病毒肺炎与抗磷脂综合征。
Autoimmun Rev. 2022 Dec;21(12):103206. doi: 10.1016/j.autrev.2022.103206. Epub 2022 Oct 3.
5
Thrombosis and hemorrhage experienced by hospitalized children with SARS-CoV-2 infection or MIS-C: Results of the PICNIC registry.因 SARS-CoV-2 感染或 MIS-C 住院的儿童的血栓形成和出血： PICNIC 登记处的结果。
Pediatr Blood Cancer. 2022 Sep;69(9):e29793. doi: 10.1002/pbc.29793. Epub 2022 Jun 11.
6
Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy.抗磷脂综合征的抗原和抗体作为 COVID-19 凝血障碍发病机制的新盟友。
Int J Mol Sci. 2022 Apr 29;23(9):4946. doi: 10.3390/ijms23094946.
7
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.1例新冠相关灾难性抗磷脂综合征经依库珠单抗成功治疗的病例报告
J Blood Med. 2021 Oct 30;12:929-933. doi: 10.2147/JBM.S324873. eCollection 2021.
8
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor.抗磷脂抗体与新冠病毒感染相关血栓形成：主角，而非配角。
Biomedicines. 2021 Jul 27;9(8):899. doi: 10.3390/biomedicines9080899.
9
The Role of Antiphospholipid Antibodies in COVID-19.抗磷脂抗体在 COVID-19 中的作用。
Curr Rheumatol Rep. 2021 Jul 14;23(9):72. doi: 10.1007/s11926-021-01041-7.
10
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019.β2糖蛋白I缺乏可能会在2019冠状病毒病患者中引发类似抗磷脂综合征的血栓前状态。
ACR Open Rheumatol. 2021 Apr;3(4):267-276. doi: 10.1002/acr2.11245. Epub 2021 Mar 19.
本文引用的文献
1
Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?补体抑制会成为治疗新冠病毒相关全身性血栓形成的新靶点吗？
Circulation. 2020 Jun 2;141(22):1739-1741. doi: 10.1161/CIRCULATIONAHA.120.047419. Epub 2020 Apr 9.
2
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
3
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.严重新型冠状病毒肺炎与非新型冠状病毒肺炎患者凝血功能特征的差异。
J Thromb Thrombolysis. 2021 May;51(4):1107-1110. doi: 10.1007/s11239-020-02105-8.
4
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".灾难性抗磷脂综合征（CAPS）：来自“CAPS注册研究”的280例患者系列的描述性分析
J Autoimmun. 2009 May-Jun;32(3-4):240-5. doi: 10.1016/j.jaut.2009.02.008. Epub 2009 Mar 26.
Zotero 插件